Therapeutic binding molecules
US12049506B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Inventors
Key dates
| Filing date | Mar 17, 2022 |
| Grant date | Jul 30, 2024 |
| Priority date | — |
| Expiry date | Mar 17, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.